Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) saw unusually-high trading volume on Monday . Approximately 1,343,201 shares traded hands during mid-day trading, an increase of 45% from the previous session’s volume of 927,215 shares.The stock last traded at $41.07 and had previously closed at $41.22. Wall Street Analysts Forecast Growth CERE […]
Certain Options of Cerevel Therapeutics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 10-DEC-2023. These Options will be under lockup for 60 days starting from 11-OCT-2023 to.
Certain Restricted stock units of Cerevel Therapeutics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 10-DEC-2023. These Restricted stock units will be under lockup for 60 days starting.
Certain Common Stock of Cerevel Therapeutics Holdings, Inc. are subject to a Lock-Up Agreement Ending on 10-DEC-2023. These Common Stock will be under lockup for 60 days starting from 11-OCT-2023 to.